Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 81,619,644
- Share change
- -2,519,721
- Total reported value
- $248,123,678
- Put/Call ratio
- 246%
- Price per share
- $3.04
- Number of holders
- 169
- Value change
- -$34,475,559
- Number of buys
- 82
- Number of sells
- 105
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
8,727,584
|
$45,296,160 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.5%
|
5,733,699
|
$29,757,898 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
4.6%
from 13D/G
|
4,784,658
|
$24,593,143 | — | 30 Sep 2024 | |
| FIL Ltd |
13F
|
Company |
4%
|
4,192,933
|
$21,761,322 | — | 30 Sep 2024 | |
| ALPINE ASSOCIATES MANAGEMENT INC. |
13F
|
Company |
4%
|
4,162,861
|
$21,605,249 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3.1%
|
3,260,471
|
$16,921,844 | — | 30 Sep 2024 | |
| Magnetar Financial LLC |
13F
|
Company |
2.4%
|
2,500,171
|
$12,975,887 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.4%
|
2,500,000
|
$12,975,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
2,433,963
|
$12,632,268 | — | 30 Sep 2024 | |
| WATER ISLAND CAPITAL LLC |
13F
|
Company |
2.3%
|
2,381,196
|
$12,358,407 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
2.2%
|
2,309,662
|
$11,987,146 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,289,654
|
$11,885,465 | — | 30 Sep 2024 | |
| LMR Partners LLP |
13F
|
Company |
2.1%
|
2,244,400
|
$11,648,436 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.8%
|
1,932,205
|
$10,028,144 | — | 30 Sep 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.8%
|
1,891,261
|
$9,815,645 | — | 30 Sep 2024 | |
| KRYGER CAPITAL Ltd |
13F
|
Company |
1.6%
|
1,667,359
|
$8,653,593 | — | 30 Sep 2024 | |
| Palo Alto Investors LP |
13F
13D/G
|
Company · Patrick Lee, MD |
1.5%
from 13D/G
|
1,611,787
|
$8,365,175 | — | 30 Sep 2024 | |
| AQR Arbitrage LLC |
13F
|
Company |
1.4%
|
1,413,103
|
$7,334,005 | — | 30 Sep 2024 | |
| Madison Avenue Partners, LP |
13F
|
Company |
1.3%
|
1,353,321
|
$7,023,736 | — | 30 Sep 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
1.1%
|
1,170,438
|
$6,208,582 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,163,371
|
$6,037,896 | — | 30 Sep 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
1%
|
1,091,164
|
$5,663,141 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
1,050,000
|
$5,449,500 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.92%
|
964,795
|
$5,007,287 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.83%
|
867,127
|
$4,500,393 | — | 30 Sep 2024 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.8%
|
839,800
|
$4,358,562 | — | 30 Sep 2024 | |
| Aubrey Rankin |
3/4/5
|
Director |
—
class O/S missing
|
570,004
|
$4,257,930 | — | 15 Mar 2022 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.78%
|
820,000
|
$4,255,800 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.76%
|
797,953
|
$4,141,376 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
790,837
|
$4,104,444 | — | 30 Sep 2024 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.7%
|
730,190
|
$3,789,686 | — | 30 Sep 2024 | |
| ODDO BHF ASSET MANAGEMENT SAS |
13F
|
Company |
0.69%
|
725,000
|
$3,762,750 | — | 30 Sep 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.67%
|
699,621
|
$3,631,033 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.6%
|
632,553
|
$3,282,950 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.54%
|
568,654
|
$2,951,314 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.54%
|
567,300
|
$2,944,287 | — | 30 Sep 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.5%
|
522,716
|
$2,712,897 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.44%
|
459,300
|
$2,383,767 | — | 30 Sep 2024 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
0.44%
|
457,085
|
$2,372,271 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.44%
|
455,313
|
$2,363,074 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.43%
|
446,027
|
$2,314,880 | — | 30 Sep 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.33%
|
347,600
|
$1,804,044 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
326,283
|
$1,693,408 | — | 30 Sep 2024 | |
| Man Group plc |
13F
|
Company |
0.29%
|
300,000
|
$1,557,000 | — | 30 Sep 2024 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.27%
|
283,800
|
$1,458,732 | — | 30 Sep 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.26%
|
275,000
|
$1,427,250 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.25%
|
265,210
|
$1,376,440 | — | 30 Sep 2024 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.23%
|
245,000
|
$1,271,550 | — | 30 Sep 2024 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.23%
|
240,000
|
$1,245,600 | — | 30 Sep 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0.22%
|
231,400
|
$1,200,966 | — | 30 Sep 2024 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q4 2024
As of 31 Dec 2024,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,619,644 shares.
The largest 10 holders included
BlackRock, Inc., Beryl Capital Management LLC, VANGUARD GROUP INC, ODDO BHF ASSET MANAGEMENT SAS, FIL Ltd, ALLIANCEBERNSTEIN L.P., Squarepoint Ops LLC, Magnetar Financial LLC, STATE STREET CORP, and ALPINE ASSOCIATES MANAGEMENT INC..
This page lists
170
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
197
Q4 2024 holders
169
Holder diff
-28
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.